Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] Hanwha Aerospace (012450) – Setting of Record Date or Closure of Register of Shareholders / 2024-12-16 Disclosures
  • [Disclosure] Samsung Electronics (005930) – (Correction) Treasury Stock Acquisition Decision / 2024-11-18 Semiconductors
  • [Disclosure] KEPCO (015760 / KEP) – (Correction) Investor Relations (IR) Announcement / 2024-08-07 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Execution of Sales / Supply Contract / 2026-03-25 Disclosures
  • [Disclosure] Jeju Semiconductor (080220) – (Correction) Change in Sales or Profit/Loss Structure by 30% (15% for Large Corporations) or More / 2025-03-14 Semiconductors
  • [Disclosure] Hanwha Ocean (042660) – Compliance Program Operation Status / 2026-02-13 Disclosures
  • [Disclosure] Hyundai Motor (005380) – Decision on Closure of Shareholders’ Register (Record Date) for Cash and In-Kind Dividend / 2026-01-29 Disclosures
  • [Disclosure] Celltrion (068270) – Approval of European Commission Marketing Authorization for Avtozma (CT-P47, Actemra/RoActemra Biosimilar) / 2025-02-24 Disclosures

[Disclosure] Celltrion (068270) – Consolidated Financial Results (Provisional Earnings Release) / 2026-07-03

Posted on July 3, 2026August 6, 2026 By K-STOCK Editor

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Celltrion reported provisional Q2 2026 consolidated revenue of KRW 1.30T and operating profit of KRW 430.0B, reflecting significant YoY increases of 35.21% and 77.32%, respectively.

📊 [Key Disclosure Details & Financial Summary]

  • Disclosure Title: Provisional Consolidated Financial Results (Fair Disclosure)
  • Reporting Period: Current Period (2026.04.01 ~ 2026.06.30) / Previous Period (2026.01.01 ~ 2026.03.31) / Same Period Last Year (2025.04.01 ~ 2025.06.30)
  • Q2 2026 Quarterly Performance (Unit: KRW)
    • Revenue: KRW 1.30T (+13.54% QoQ, +35.21% YoY)
    • Operating Profit: KRW 430.0B (+33.58% QoQ, +77.32% YoY)
  • H1 2026 Cumulative Performance (Unit: KRW)
    • Cumulative Revenue: KRW 2.45T (+35.58% YoY vs. KRW 1.80T in H1 2025)
    • Cumulative Operating Profit: KRW 751.9B (+91.86% YoY vs. KRW 391.9B in H1 2025)
  • Information Provider & Date: Celltrion IR Department, July 3, 2026
  • Key Notes: Figures are provisional K-IFRS consolidated internal estimates prior to external audit review, with re-disclosure scheduled during the Q2 2026 Investor Relations conference.

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of Final Audited Figures and Detailed Financial Notes

Because this filing presents unaudited provisional results based on internal settlement, it is important to monitor potential variances against the final audited statements. Unreported items such as net income and detailed revenue breakdowns by business segment will be verified upon the submission of the upcoming Half-Yearly Business Report under the consolidated financial statements and notes.

📢 Disclaimer & Source Information

Source: This content was newly generated and structured based on official data submitted to the Data Analysis, Retrieval and Transfer System (DART) of the Financial Supervisory Service.

Investment Risk Notice: This information is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial responsibilities rest solely with the investor.

Contact: For compliance inquiries or copyright concerns, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Bio & Healthcare

Post navigation

Previous Post: [Disclosure] Hanwha Aerospace (012450) – Future Business and Management Plan (Fair Disclosure) / 2026-07-03
Next Post: [Disclosure] Samsung Electro-Mechanics (009150) – Future Business/Management Plan (Fair Disclosure) / 2026-07-03

Related Posts

  • [Disclosure] Samsung Biologics (207940) – (Correction) Major Management Matters Related to Investment Decisions / 2024-10-29 Disclosures
  • [Disclosure] Hana Micron (067310) – Results of Annual General Meeting of Shareholders / 2024-03-28 Disclosures
  • [Disclosure] Hanmi Semiconductor (042700) – Decision on General Meeting of Shareholders / 2025-02-19 Semiconductors
  • [Disclosure] Hanmi Semiconductor (042700) – Consolidated Financial Results (Provisional) (Fair Disclosure) / 2026-07-14 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Sales and Supply Contract / 2025-04-01 Disclosures
  • [Disclosure] ISU PETASYS (007660) – Decision on Calling of General Shareholders Meeting / 2026-03-23 Semiconductors
  • [Disclosure] Celltrion (068270) – Decision on Retirement of Shares / 2026-03-24 Disclosures
  • [Disclosure] HPSP (403870) – Additional Listing (Exercise of Stock Options) / 2024-12-13 Semiconductors
  • [Research] SK hynix (000660 / SKHY) – Hyundai Motor Securities | HBM Growth Potential · Target P/B Upgraded · Blackwell Ultra Effect / 2025-06-26 RESEARCH
  • [Disclosure] Hanmi Semiconductor (042700) – Investor Relations (IR) Holding / 2026-06-22 Semiconductors
  • [Disclosure] Hanwha Aerospace (012450) – Execution of Single Sales or Supply Contract / 2024-02-20 Disclosures
  • [Disclosure] KEPCO (015760 / KEP) – Decision to Convene General Meeting of Shareholders / 2026-04-10 Disclosures
  • [Disclosure] Hanwha Systems (272210) – (Correction) Investor Relations (IR) Announcement / 2026-02-06 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Submission of Audit Report / 2025-03-12 Disclosures

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme